Clinical chemistry and dried blood spots: increasing laboratory utilization by improved understanding of quantitative challenges
A validated LC–MS/MS method for the quantification of piperacillin/tazobactam on dried blood spot
Bioanalytical comparison between dried urine spots and liquid urine bioassays used for the quantitative analysis of urinary creatinine concentrations
Development of a UPLC–MS/MS method for the quantification of sildenafil by DBS, and its use on pediatric pulmonary hypertension
Dried blood spot analysis to assess medication adherence and to inform personalization of treatment
Future applications of high-resolution MS to meet the demands for pain management drug testing
Bias in clinical chemistry
Heterogeneous and homogeneous immunoassays for drug analysis
Modern LC in therapeutic drug monitoring and diagnosis of pediatric leukemia
Paper microfluidics in bioanalysis
Summary of the 2014 Land O'Lakes Bioanalytical Conference
Method validation of the biochip array technology for synthetic cannabinoids detection in urine
Quantitative analysis of bisphosphonates in biological samples